Please wait

 

United States

Securities and Exchange Commission

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

☐

Preliminary Proxy Statement

☐

Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐

Definitive Proxy Statement

☒

Definitive Additional Materials

☐

Soliciting Materials under § 240.14a-12

 

ZOMEDICA CORP.

(Name of Registrant as Specified in Its Charter)

 

_________________________________________________________ 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

☒

No fee required.

☐

Fee paid previously with preliminary materials.

 

 

☐

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

On May 24, 2025, Zomedica Corp. sent the following message to its shareholders registered with Say Technologies, LLC (“Say”) via Say’s shareholder communication platform relating to its 2025 Annual Meeting of Shareholders:

 

 

 

 

Zomedica

 

 

 

 

 

 

Hi [shareholder name],

 

As described in our proxy, our Annual Shareholder Meeting will be held virtually on June 10 at 11:00 am EDT. In order to ensure that your vote counts, please use the VOTE button below.

 

To support your decision making, we've shared a number of key updates over the past few weeks. On May 15, we filed our 10-Q, providing a comprehensive overview of our financial performance for Q1, along with a Form 8-K that includes our earnings press release.

 

Looking ahead, we are excited to host our first Fourth Friday Webinar, where we'll take a close look at our flagship product - the PulseVet Shock Wave System. This will be an informative and engaging session, offering insight into the product's value, market potential and relevance to our broader strategy. We'll also answer key investor questions and provide the context you need to feel confident in your investment.

 

 

 

 

 

 

 

Vote now

 

 

 

 

 

 

 

Larry Heaton

 

Chief Executive Officer, Zomedica

 

 

 

 

 

 

Don't want to receive shareholder messages from Zomedica? Opt out

 

 

 

 

 

 

Say Technologies LLC is a third party provider of shareholder engagement services to and on behalf of public companies. This message and its contents (collectively, this “Content”) is sent by the aforementioned issuer and provided for informational purposes only. This Content is not intended to provide financial, legal, tax or investment advice or recommendations. You are receiving this Content because you are a shareholder of the aforementioned issuer. This Content may contain insights and/or opinions that do not reflect the views of Say Technologies LLC or any of its subsidiaries or affiliates. Say Technologies LLC makes no representations or warranties as to the suitability, accuracy, completeness, or timeliness of the Content provided, including any information provided by third parties. This is an automated message. If you want to contact us, please do not reply to this message but instead send Say support a message here. Replies to this message will not be read or responded to. Read here for more information on our Privacy Policy.